<p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Offences relating to therapeutic products</p><ul class="Section ProvisionList" id="234651"><li><p class="Subsection" id="1174194"><strong><a class="sectionLabel" id="s-31.2"><span class="sectionLabel">31.2</span></a></strong> <span class="lawlabel">(1)</span> Subject to section 31.4, every person who contravenes any provision of this Act or the regulations, as it relates to a therapeutic product, or an order made under any of sections 21.1 to 21.32 is guilty of an offence and liable</p><ul class="ProvisionList"><li><p class="Paragraph" id="1174195"><span class="lawlabel">(a)</span> on conviction by indictment, to a fine not exceeding $5,000,000 or to imprisonment for a term not exceeding two years or to both; and</p></li><li><p class="Paragraph" id="1174196"><span class="lawlabel">(b)</span> on summary conviction, for a first offence, to a fine not exceeding $250,000 or to imprisonment for a term not exceeding six months or to both and, for a subsequent offence, to a fine not exceeding $500,000 or to imprisonment for a term not exceeding 18 months or to both.</p></li></ul></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Clarification</p><p class="Subsection" id="1174197"><span class="lawlabel">(2)</span> For greater certainty, subsection (1) applies in respect of the following provisions of this Act:</p><ul class="ProvisionList"><li><p class="Paragraph" id="1174199"><span class="lawlabel">(a)</span> section 3, if the contravention of that section involves a therapeutic product;</p></li><li><p class="Paragraph" id="1249412"><span class="lawlabel">(a.1)</span> section 3.1 or 3.3, if the contravention of that section involves a clinical trial that relates to a therapeutic product;</p></li><li><p class="Paragraph" id="1249413"><span class="lawlabel">(a.2)</span> section 3.2, if the contravention of that section involves the terms and conditions of an authorization that authorizes the conduct of a clinical trial that relates to a therapeutic product;</p></li><li><p class="Paragraph" id="1174200"><span class="lawlabel">(b)</span> subsection 22.1(2), if the contravention of that subsection involves any document or information that relates to a therapeutic product or a sample that is or relates to a therapeutic product;</p></li><li><p class="Paragraph" id="1174201"><span class="lawlabel">(c)</span> subsection 23(6), if the contravention of that subsection involves a conveyance in respect of which an inspector is exercising powers or performing duties or functions in relation to a therapeutic product;</p></li><li><p class="Paragraph" id="1174202"><span class="lawlabel">(d)</span> subsection 23(13), if the contravention of that subsection involves a place in which an inspector is exercising powers or performing duties or functions in relation to a therapeutic product;</p></li><li><p class="Paragraph" id="1174203"><span class="lawlabel">(e)</span> subsection 24(1), if the contravention of that subsection involves the obstruction or hindering of — or the making of a false or misleading statement to — an inspector who is carrying out duties or functions in relation to a therapeutic product;</p></li><li><p class="Paragraph" id="1174204"><span class="lawlabel">(f)</span> subsection 24(2), if the contravention of that subsection involves anything seized that is or relates to a therapeutic product; and</p></li><li><p class="Paragraph" id="1174205"><span class="lawlabel">(g)</span> subsection 27.3(2), if the contravention of that subsection involves measures that were ordered to be taken in relation to a therapeutic product.</p></li></ul></li></ul><div class="HistoricalNote"><ul class="HistoricalNote"><li class="HistoricalNoteSubItem">2014, c. 24, ss. 9, 10</li><li class="HistoricalNoteSubItem">2019, c. 29, s. 174</li></ul></div>